Cutaneous Leukocytoclastic Vasculitis Induction Following ChAdOx1 nCoV-19 Vaccine.

chadox1 ncov-19 covid-19 cutaneous vasculitis immune response vaccine

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
Oct 2021
Historique:
accepted: 24 10 2021
entrez: 2 12 2021
pubmed: 3 12 2021
medline: 3 12 2021
Statut: epublish

Résumé

The coronavirus disease 2019 (COVID-19) pandemic is an unprecedented event, and in order to control its spread and minimize its damages, all efforts are immediately mobilized. Mass vaccination is considered a promising solution to combat this universal issue. However, given the urgent need for vaccine production, some of the side effects may not have been presented during trials and will only appear during the mass vaccination. Limited vasculitis cases have been reported so far following vaccination against COVID-19. We present a case of cutaneous leukocytoclastic vasculitis (LCV) induced following the first dose of the ChAdOx1 nCoV-19 vaccine in an otherwise healthy individual.

Identifiants

pubmed: 34853744
doi: 10.7759/cureus.19005
pmc: PMC8609955
doi:

Types de publication

Case Reports

Langues

eng

Pagination

e19005

Informations de copyright

Copyright © 2021, Shahrigharahkoshan et al.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Eur J Dermatol. 1998 Mar;8(2):75-9
pubmed: 9649707
J Eur Acad Dermatol Venereol. 2021 Nov;35(11):e745-e747
pubmed: 34310759
Eur J Cancer. 2021 May;148:316-327
pubmed: 33770576
J Thromb Thrombolysis. 2020 Oct;50(3):499-511
pubmed: 32700024
J Eur Acad Dermatol Venereol. 2020 Aug;34(8):e362-e363
pubmed: 32378747
Dermatol Ther. 2021 Sep;34(5):e15093
pubmed: 34369046
Am J Kidney Dis. 2021 Oct;78(4):611-613
pubmed: 34280507
J Drugs Dermatol. 2021 Mar 1;20(3):351-352
pubmed: 33683080
Int J Dermatol. 2021 Aug;60(8):1032-1033
pubmed: 33928638
J Autoimmun. 2021 Jul;121:102663
pubmed: 34020254
Lancet. 2021 Jan 9;397(10269):99-111
pubmed: 33306989
J Am Acad Dermatol. 2021 Jul;85(1):46-55
pubmed: 33838206
Vaccine. 2016 Dec 12;34(51):6641-6651
pubmed: 26398442
Br J Dermatol. 2020 Oct;183(4):778-780
pubmed: 32585767

Auteurs

Shaghayegh Shahrigharahkoshan (S)

Dermatology, Laval University, Quebec City, CAN.

Louis-Philippe Gagnon (LP)

Pathology, Laval University, Quebec City, CAN.

Steve Mathieu (S)

Dermatology, Laval University, Quebec City, CAN.

Classifications MeSH